MDxHealth Statistics
Total Valuation
MDxHealth has a market cap or net worth of $118.65 million. The enterprise value is $176.12 million.
Important Dates
The next confirmed earnings date is Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MDxHealth has 51.36 million shares outstanding. The number of shares has increased by 52.05% in one year.
| Current Share Class | 51.36M |
| Shares Outstanding | 51.36M |
| Shares Change (YoY) | +52.05% |
| Shares Change (QoQ) | +4.90% |
| Owned by Insiders (%) | 6.46% |
| Owned by Institutions (%) | 30.04% |
| Float | 35.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.10 |
| Forward PS | 0.84 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.08
| Current Ratio | 1.08 |
| Quick Ratio | 0.89 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.24 |
Financial Efficiency
Return on equity (ROE) is -2,440.41% and return on invested capital (ROIC) is -12.05%.
| Return on Equity (ROE) | -2,440.41% |
| Return on Assets (ROA) | -5.90% |
| Return on Invested Capital (ROIC) | -12.05% |
| Return on Capital Employed (ROCE) | -14.64% |
| Weighted Average Cost of Capital (WACC) | -1,708,940.85% |
| Revenue Per Employee | $345,753 |
| Profits Per Employee | -$107,433 |
| Employee Count | 312 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 7.21 |
Taxes
| Income Tax | -1.86M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49.52% in the last 52 weeks. The beta is -537,510.36, so MDxHealth's price volatility has been lower than the market average.
| Beta (5Y) | -537,510.36 |
| 52-Week Price Change | +49.52% |
| 50-Day Moving Average | 3.02 |
| 200-Day Moving Average | 3.40 |
| Relative Strength Index (RSI) | 39.30 |
| Average Volume (20 Days) | 259,325 |
Short Selling Information
The latest short interest is 73,632, so 0.09% of the outstanding shares have been sold short.
| Short Interest | 73,632 |
| Short Previous Month | 39,057 |
| Short % of Shares Out | 0.09% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.35 |
Income Statement
In the last 12 months, MDxHealth had revenue of $107.88 million and -$33.52 million in losses. Loss per share was -$0.67.
| Revenue | 107.88M |
| Gross Profit | 69.63M |
| Operating Income | -14.41M |
| Pretax Income | -35.38M |
| Net Income | -33.52M |
| EBITDA | -7.06M |
| EBIT | -14.41M |
| Loss Per Share | -$0.67 |
Full Income StatementBalance Sheet
The company has $29.14 million in cash and $86.60 million in debt, with a net cash position of -$57.47 million or -$1.12 per share.
| Cash & Cash Equivalents | 29.14M |
| Total Debt | 86.60M |
| Net Cash | -57.47M |
| Net Cash Per Share | -$1.12 |
| Equity (Book Value) | -12.09M |
| Book Value Per Share | -0.24 |
| Working Capital | 3.88M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.19 million and capital expenditures -$1.16 million, giving a free cash flow of -$3.35 million.
| Operating Cash Flow | -2.19M |
| Capital Expenditures | -1.16M |
| Depreciation & Amortization | 7.35M |
| Net Borrowing | 21.60M |
| Free Cash Flow | -3.35M |
| FCF Per Share | -$0.07 |
Full Cash Flow StatementMargins
Gross margin is 64.55%, with operating and profit margins of -13.36% and -31.07%.
| Gross Margin | 64.55% |
| Operating Margin | -13.36% |
| Pretax Margin | -32.79% |
| Profit Margin | -31.07% |
| EBITDA Margin | -6.54% |
| EBIT Margin | -13.36% |
| FCF Margin | n/a |
Dividends & Yields
MDxHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -52.05% |
| Shareholder Yield | -52.05% |
| Earnings Yield | -28.25% |
| FCF Yield | -2.82% |
Analyst Forecast
The average price target for MDxHealth is $7.67, which is 232.04% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.67 |
| Price Target Difference | 232.04% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 21.73% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 14, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Nov 14, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
MDxHealth has an Altman Z-Score of -2.88 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.88 |
| Piotroski F-Score | 3 |
